Century Therapeutics, a biotech company developing stem cell therapies for autoimmune diseases like type 1 diabetes, announced it will attend the 2026 Jefferies Global Healthcare Conference in London on November 18, 2026. The event offers an opportunity for investors and partners to engage with Century's team and learn about their innovative iPSC-derived cell therapies leveraging Allo-Evasion™ technology. This participation highlights Century's ongoing efforts to advance off-the-shelf cell therapies that could improve treatment access and outcomes for patients. Interested parties can arrange one-on-one meetings through Jefferies representatives.
Century Therapeutics' upcoming attendance at the 2026 Jefferies Global Healthcare Conference is noted alongside Pluang's health sector market data. For readers following health stocks, as of Oct 14, 2026 19:01 WIB, 105 of 150 priced US health-sector stocks on Pluang rose while 40 fell. Notable movers include ClearPoint Neuro Inc (CLPT) with a price of USD 10.14 and a 1-day change of +3.36%, Guardant Health Inc (GH) at USD 158.20 down -2.40%, and DENTSPLY SIRONA Inc (XRAY) at USD 8.69 up +2.18%.
Genesis Global won the Best AI Solution for Software Development award at the 2026 AI in Capital Markets Awards for its product Genesis Create. This software combines AI with reusable components and financial expertise to help firms develop productio...
nuVizz has been recognized as an Accelerator in the 2026 Nucleus Research Transportation Management Value Matrix for its specialized last-mile delivery technology. The platform excels in coordinating complex delivery networks involving private fleets...
ASML Holding posted a strong Q3 2026 earnings per share of $14.65, beating estimates of $12.17, driven by a 55% year-over-year sales growth and a 57.5% gross margin. Although revenue was slightly below expectations at $13.05 billion, the company bene...
Charles Schwab is set to report its Q3 2026 earnings with an estimated EPS of $1.66 and revenue around $7.18-$7.19 billion, reflecting significant growth driven by an 18.2% increase in trading revenue, net interest income, and asset management fees. ...
Transmission System Operators (TSOs) are increasingly investing in software like Energy Management Systems and grid planning tools to modernize aging infrastructure, enhance cybersecurity, and expand grid capacity. Cybersecurity remains their top con...
